Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)
Clinical trial NCT01926509 · COMPLETED
Trial details
- NCT number
- NCT01926509
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-14
- Primary completion
- 2014-09-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.